1. Home
  2. INVZ vs CGEN Comparison

INVZ vs CGEN Comparison

Compare INVZ & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INVZ
  • CGEN
  • Stock Information
  • Founded
  • INVZ 2016
  • CGEN 1993
  • Country
  • INVZ Israel
  • CGEN Israel
  • Employees
  • INVZ N/A
  • CGEN N/A
  • Industry
  • INVZ Auto Parts:O.E.M.
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • INVZ Consumer Discretionary
  • CGEN Health Care
  • Exchange
  • INVZ Nasdaq
  • CGEN Nasdaq
  • Market Cap
  • INVZ 186.3M
  • CGEN 167.4M
  • IPO Year
  • INVZ N/A
  • CGEN 2000
  • Fundamental
  • Price
  • INVZ $1.58
  • CGEN $1.65
  • Analyst Decision
  • INVZ Strong Buy
  • CGEN
  • Analyst Count
  • INVZ 5
  • CGEN 0
  • Target Price
  • INVZ $3.38
  • CGEN N/A
  • AVG Volume (30 Days)
  • INVZ 8.5M
  • CGEN 265.0K
  • Earning Date
  • INVZ 08-06-2025
  • CGEN 08-05-2025
  • Dividend Yield
  • INVZ N/A
  • CGEN N/A
  • EPS Growth
  • INVZ N/A
  • CGEN N/A
  • EPS
  • INVZ N/A
  • CGEN N/A
  • Revenue
  • INVZ $34,601,000.00
  • CGEN $27,589,000.00
  • Revenue This Year
  • INVZ $137.25
  • CGEN N/A
  • Revenue Next Year
  • INVZ $128.53
  • CGEN $173.80
  • P/E Ratio
  • INVZ N/A
  • CGEN N/A
  • Revenue Growth
  • INVZ 28.52
  • CGEN N/A
  • 52 Week Low
  • INVZ $0.45
  • CGEN $1.13
  • 52 Week High
  • INVZ $3.14
  • CGEN $2.66
  • Technical
  • Relative Strength Index (RSI)
  • INVZ 77.76
  • CGEN 51.95
  • Support Level
  • INVZ $1.20
  • CGEN $1.58
  • Resistance Level
  • INVZ $1.58
  • CGEN $1.81
  • Average True Range (ATR)
  • INVZ 0.15
  • CGEN 0.08
  • MACD
  • INVZ 0.05
  • CGEN -0.01
  • Stochastic Oscillator
  • INVZ 91.51
  • CGEN 20.00

About INVZ Innoviz Technologies Ltd. Ordinary shares

Innoviz Technologies Ltd is a provider of solid-state LiDAR and perception solutions that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. The company provides a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger cars and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks and other industries that require 3-dimensional high resolution sensors. Company's solutions can enable safe autonomy for industries like logistics, drones, robotics, construction and other industrial applications, agriculture, smart city, smart infrastructure, security and mapping.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

Share on Social Networks: